| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fbef4618e4de478f246efe97ea292cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39b2b85556ba0dbab6faa9e60acf88b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2848 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
| filingDate |
2006-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-04-10^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bad0558e4f2dd128fd52291859d7d650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be0fce6f8e623132c8049d8b54ad158 |
| publicationDate |
2012-04-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8152784-B2 |
| titleOfInvention |
Method for treating or preventing steroid-induced glaucoma |
| abstract |
An integrin antagonist reduces the occurrence of cross-linked actin network (CLAN) structures in cells of the trabecular meshwork. CLAN structures are associated with steroid-induced glaucoma. Reduction in CLAN structures is associated with increased aqueous humor outflow facility from the trabecular meshwork. |
| priorityDate |
2005-02-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |